BLOC1S1 and hepatocellular carcinoma: To further investigate the mechanism whereby mitochondrial‐enriched GCN5L1 modulates HCC development, we employed CRISPR technology targeting exon 1 or exon 2 of GCN5L1 to delete endogenous GCN5L1 in human HCC cell lines (HepG2 and Huh7).